Toshitaka Nagao
Papers
1
Total Citations
11
H-Index
1
About
Dr. Toshitaka Nagao is a leading urological pathologist whose research focuses on refining prostate cancer prognostication through detailed histopathological analysis. His major contributions center on the clinical significance of cribriform morphology—a specific growth pattern within Gleason pattern 4 tumors—and its correlation with biochemical recurrence (BCR) after radical prostatectomy. In his landmark 2024 study, Dr. Nagao demonstrated that the ratio of cribriform morphology area is a critical predictor of BCR in patients with Gleason score 4+4 prostate cancer following robot-assisted radical prostatectomy. This work, which has already garnered 11 citations, provides surgeons and oncologists with a more precise tool for risk stratification, moving beyond traditional Gleason grading alone. By isolating the impact of cribriform pattern size and percentage in a previously understudied homogeneous cohort, Dr. Nagao has advanced personalized treatment planning, helping to identify patients who may benefit from adjuvant therapies versus those who can safely undergo active surveillance. His research bridges pathology and clinical urology, offering actionable insights that improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1